The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S)-N-[(1S)-1-[4-carbamoyl-2-(4-fluorophenyl)-1H-imidazol-5-yl]-7-oxo-nonyl]-6-ethyl-6-azaspiro[2.5]octane-2-carboxamide ID: ALA4785376
PubChem CID: 162665723
Max Phase: Preclinical
Molecular Formula: C29H40FN5O3
Molecular Weight: 525.67
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCC(=O)CCCCC[C@H](NC(=O)[C@H]1CC12CCN(CC)CC2)c1[nH]c(-c2ccc(F)cc2)nc1C(N)=O
Standard InChI: InChI=1S/C29H40FN5O3/c1-3-21(36)8-6-5-7-9-23(32-28(38)22-18-29(22)14-16-35(4-2)17-15-29)24-25(26(31)37)34-27(33-24)19-10-12-20(30)13-11-19/h10-13,22-23H,3-9,14-18H2,1-2H3,(H2,31,37)(H,32,38)(H,33,34)/t22-,23+/m1/s1
Standard InChI Key: QEADHPNYEASZRQ-PKTZIBPZSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
34.8214 -25.5063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2300 -26.2162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0431 -26.2187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4537 -25.5131 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.0492 -24.8032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2300 -24.7990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4187 -24.0658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4175 -24.8895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1297 -25.2985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8435 -24.8890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8407 -24.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1279 -23.6528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5487 -23.6485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3006 -23.9780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.8493 -23.3687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4339 -22.6584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6311 -22.8314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6665 -23.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0016 -24.2005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1443 -22.7840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7634 -21.9064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5799 -21.8179 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2805 -21.2430 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.9614 -22.8664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4434 -22.1993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2606 -22.2817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7384 -21.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5556 -21.7011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0375 -21.0340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8949 -22.4505 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.8547 -21.1164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8188 -24.2828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1540 -25.0322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3008 -23.6158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.7054 -25.2975 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.0724 -25.8482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2750 -25.5168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6804 -26.2264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 13 2 0
11 13 1 0
15 18 1 0
18 19 1 6
18 20 1 0
16 21 1 0
21 22 1 0
21 23 2 0
20 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
28 30 2 0
29 31 1 0
19 32 1 0
33 32 1 6
32 34 2 0
8 35 1 0
36 33 1 0
1 36 1 0
33 1 1 0
4 37 1 0
37 38 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 525.67Molecular Weight (Monoisotopic): 525.3115AlogP: 4.52#Rotatable Bonds: 13Polar Surface Area: 121.18Molecular Species: BASEHBA: 5HBD: 3#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.35CX Basic pKa: 9.00CX LogP: 3.01CX LogD: 1.79Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -0.43
References 1. Clausen DJ,Liu J,Yu W,Duffy JL,Chung CC,Myers RW,Klein DJ,Fells J,Holloway K,Wu J,Wu G,Howell BJ,Barnard RJO,Kozlowski J. (2020) Development of a selective HDAC inhibitor aimed at reactivating the HIV latent reservoir., 30 (17.0): [PMID:32738976 ] [10.1016/j.bmcl.2020.127367 ] 2. Yu W, Fells J, Clausen D, Liu J, Klein DJ, Christine Chung C, Myers RW, Wu J, Wu G, Howell BJ, Barnard RJO, Kozlowski J.. (2021) Discovery of macrocyclic HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation., 47 [PMID:34091041 ] [10.1016/j.bmcl.2021.128168 ]